Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
VACCINEX, INC. | SVP, Research & CSO | Stock Option (Right to Buy) | 1.34K | $5.31K | $3.96 | Mar 21, 2024 | Direct |
VACCINEX, INC. | SVP, Research & CSO | Common Stock | 39 | $28.30 | $0.73 | Mar 20, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
VCNX | VACCINEX, INC. | Mar 21, 2024 | 1 | $0 | 4/A | May 14, 2024 | SVP, Research & CSO |
VCNX | VACCINEX, INC. | Mar 20, 2024 | 1 | $0 | 4 | Mar 22, 2024 | SVP, Research & CSO |
VCNX | VACCINEX, INC. | Mar 31, 2023 | 1 | $0 | 4 | Apr 3, 2023 | SVP, Research & CSO |
VCNX | VACCINEX, INC. | Apr 1, 2022 | 1 | $0 | 4 | Apr 4, 2022 | SVP, Research & CSO |